Gara Jalqabaatti › COPD › Florida
Qorannoo klinikaalii COPD Florida keessatti
Qorannoo 28 COPD f Florida keessatti hirmaatuu jiru.
Magaalota Florida keessatti
- MiamiQorannoo 18
- OrlandoQorannoo 15
- HialeahQorannoo 9
- TampaQorannoo 8
- KendallQorannoo 8
- West Palm BeachQorannoo 6
- JacksonvilleQorannoo 6
- St. PetersburgQorannoo 5
- DeltonaQorannoo 5
- OcalaQorannoo 5
- DoralQorannoo 4
- BrandonQorannoo 4
- Boca RatonQorannoo 4
- PlantationQorannoo 3
- ClearwaterQorannoo 3
- Cape CoralQorannoo 3
- Coral SpringsQorannoo 3
- Palm CoastQorannoo 3
- NaplesQorannoo 3
Takkalaa qorannoo (Ingiliffa)
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- GSK Investigational Site, Brooksville
- GSK Investigational Site, Doral
- GSK Investigational Site, Fort Lauderdale
- fi 16 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 40 hanga 80 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT06961214Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation
- GSK Investigational Site, Bradenton
- GSK Investigational Site, Brandon
- GSK Investigational Site, Hialeah
- fi 12 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 40 hanga 80 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT06959095A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Boynton Beach
- Research Site, Bradenton
- Research Site, Cape Coral
- fi 25 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 40 hanga 80 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06283966Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Meris Clinical Research- Site Number : 8400153, Brandon
- Hillcrest Medical Research- Site Number : 8400082, DeLand
- Finlay Medical Research - Greenacres- Site Number : 8400107, Greenacres City
- fi 18 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 40 hanga 80 · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT07190222To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
- International Clinical Research, Altamonte Springs
- Nature Coast Clinical Research, Crystal River
- Clinical Site Partners, LLC Leesburg dba Flourish Research, Leesburg
- fi 2 dabalataa
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 40 hanga 85 · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07684820A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-2)
- GSK Investigational Site, Miami
- GSK Investigational Site, Tampa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 40 hanga 80 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07780656A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
- Millennium Medical Research - Miami, Miami
- Deluxe Health Center, Miami Lakes
- Florida Institute For Clinical Research, LLC, Orlando
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 40 hanga 75 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07759245Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Helix Biomedics- Site Number : 8400065, Boynton Beach
- Beautiful Minds Clinical Research Center- Site Number : 8400017, Cutler Bay
- Eastern Medical Group Research- Site Number : 8400020, Fort Myers
- fi 10 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 40 hanga 80 · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07190209A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
- University of Miami Dermatology Clinical Trials Unit- Site Number : 8400015, Miami
- Finlay Medical Research- Site Number : 8400010, Miami
Namoota walitti qabaa jiraSadarkaa 4
Umuriin 40 hanga 85 · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07053423A Study to Evaluate the Long-term Safety and Efficacy of Lunsekimig in Adult Participants With Chronic Obstructive Pulmonary Disease (COPD)
- Helix Biomedics- Site Number : 8403065, Boynton Beach
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 40 hanga 80 · Saalaa hunda · Haaromfame 21-Ful-2026 · NCT07793409An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
- Orlando Health, Orlando
Namoota walitti qabaa jira
Umuriin 40 hanga 80 · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT06035120A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)
- WB Contracted Clinical Research Site, Miami Lakes
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 40 hanga 80 · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT07646587A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-1)
- GSK Investigational Site, Doral
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 40 hanga 80 · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT07780669A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Brandon
- Research Site, Cape Coral
- Research Site, Clearwater
- fi 17 dabalataa
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 40 fi ol · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT07082738Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- University of Florida, Jacksonville
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 40 fi ol · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT07059091A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Clearwater
- Research Site, Cutler Bay
- Research Site, Cutler Bay
- fi 9 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 40 hanga 80 · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT06883305A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Bay Pines
- Research Site, Boynton Beach
- Research Site, Jacksonville
- fi 5 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 40 hanga 80 · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT06878261A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- Finlay Medical Research, Greenacres City
- Clinical Research Specialists LLC, Kissimmee
- Advanced Pulmonary Research Institute, Loxahatchee Groves
- fi 9 dabalataa
Namoota walitti qabaa jiraSadarkaa 2/3
Umuriin 35 hanga 80 · Saalaa hunda · Haaromfame 31-Hag-2026 · NCT07363694Rademikibart IV for Acute Asthma and COPD Exacerbation
- Columbus Clinical Services, LLC, Miami
- Pharmax Research of South Florida, Inc., Miami
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 85 · Saalaa hunda · Haaromfame 27-Hag-2026 · NCT07705737Alpha-1 Research Registry
- Alpha-1 Foundation, Coral Gables
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin hundi · Saalaa hunda · Haaromfame 19-Hag-2026 · NCT04157049A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
- GC2501 Study Site 103, Gainesville
- GC2501 Study Site 105, Miami
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 11-Hag-2026 · NCT07555483STRIVE Post-Market Registry Study
- University of Miami, Coral Gables
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 03-Hag-2026 · NCT04302272eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- GSK Investigational Site, Brandon
- GSK Investigational Site, Crystal River
- GSK Investigational Site, Doral
- fi 8 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 40 hanga 75 · Saalaa hunda · Haaromfame 28-Ado-2026 · NCT07177339Physiologic Effects of Nasal High Flow on Exercise Tolerance in COPD
- University of Miami, Miami
Namoota walitti qabaa jira
Umuriin 18 hanga 100 · Saalaa hunda · Haaromfame 22-Wax-2026 · NCT06578156Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
- Mayo Clinic Jacksonville, Jacksonville
Namoota walitti qabaa jira
Umuriin 40 hanga 80 · Saalaa hunda · Haaromfame 28-Elb-2026 · NCT07051707Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
- Mayo Clinic, Jacksonville
- Orlando Health, Orlando
Namoota walitti qabaa jira
Umuriin 40 hanga 84 · Saalaa hunda · Haaromfame 24-Elb-2026 · NCT06891755Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Hillcrest Medical Research, DeLand
- Universal Axon Clinical Research, Doral
- I.H.S Health, LLC, Kissimmee
- fi 3 dabalataa
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 50 fi ol · Saalaa hunda · Haaromfame 05-Hag-2025 · NCT06122077myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
- University of Florida, Jacksonville, Jacksonville
- Alloy Clinical Research, Kissimmee
- Reliable Research, Inc., Miami
- fi 2 dabalataa
Namoota walitti qabaa jira
Umuriin 30 fi ol · Saalaa hunda · Haaromfame 06-Gur-2025 · NCT05204888Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.